AQST
Aquestive Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.61
−1.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -10.23x
- Price / sales
- 10.70x
- Price / cash flow
- -12.75x
Enterprise value
- Enterprise value
- $539.1M
- EV / sales
- 9.97x
- EV / EBITDA
- -8.80x
- EV / EBIT
- -10.22x
- Market cap
- $578.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026